Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Serag, H B
Right arrow Articles by Key, C R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Serag, H B
Right arrow Articles by Key, C R
Gut 2002;50:368-372
© 2002 by Gut


CANCER

Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA

H B El-Serag1, A C Mason2, N Petersen3, C R Key2

1 Sections of Gastroenterology and Health Services Research, Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
2 University of New Mexico, Albuquerque, New Mexico, USA
3 Health Services Research Section, Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA

Correspondence to:
Correspondence to:
Dr H B El-Serag, Houston VA Medical Center (152), 2002 Holcombe Boulevard, Houston, TX 77030, USA.
hasheme{at}bcm.tmc.edu

Background and aims: It has been suggested that gastric cardia adenocarcinoma (GCA) is a distinct entity from oesophageal adenocarcinoma (OA). We examined several epidemiological features of GCA and OA in the USA to elucidate differences/similarities between these malignancies.

Methods: Using the database of Surveillance, Epidemiology, and End Results (SEER) program, we examined incidence rates for temporal changes, and ethnic and age distributions, and performed birth cohort analyses for cases with morphologically and histologically confirmed OA or GCA.

Results: The age adjusted incidence rates of OA rose progressively, reaching 1.8 per 100 000 (95% confidence interval 1.7–1.9) during 1987–1991 and 2.5 per 100 000 (2.3–2.6) during 1992–1996. In 1992–1996, Whites were affected five times more than Blacks, and men eight times more than women. A significant increase in incidence occurred among younger persons aged 45–65 years. Irrespective of age, OA was characterised by higher incidence rates among more recent birth cohorts: a 40% increase in incidence for each five year increase in the date of birth—a "birth cohort effect". On the other hand, the incidence rates of GCA reached their highest level of 3.3 per 100 000 (3.2–3.4) in 1987–1991 and subsequently declined during 1992–1996 to 3.1 per 100 000 (3.0–3.3). Whites were affected twice more than blacks and men five times more than women. Most patients with GCA were older than 60 years with no increase among younger persons and no birth cohort effect (p=0.99).

Conclusion: Several significant epidemiological differences exist between OA and GCA. These differences suggest that these two malignancies are separate entities with different risk factors.


Keywords: oesophageal adenocarcinoma; gastric cardia adenocarcinoma; gastro-oesophageal reflux disease; epidemiology

Abbreviations: OA, oesophageal adenocarcinoma; GCA, gastric cardia adenocarcinoma; GORD, gastro-oesophageal reflux disease; SEER, Surveillance, Epidemiology, and End Results; BMI, body mass index; IM, intestinal metaplasia




This article has been cited by other articles:


Home page
Cancer Res.Home page
C.-J. Yen, J. G. Izzo, D.-F. Lee, S. Guha, Y. Wei, T.-T. Wu, C.-T. Chen, H.-P. Kuo, J.-M. Hsu, H.-L. Sun, et al.
Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma
Cancer Res., April 15, 2008; 68(8): 2632 - 2640.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J. Lenglinger, M. Eisler, M. Riegler, S. Hansen, S. E. Vollset, M. H Derakhshan, and K. E L McColl
Single aetiology and dual associations of cardiac cancer * Authors' reply
Gut, October 1, 2007; 56(10): 1484 - 1485.
[Full Text] [PDF]


Home page
GutHome page
R C Fitzgerald
Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.
Gut, December 1, 2006; 55(12): 1810 - 1820.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. A. Gonzalez, P. Jakszyn, G. Pera, A. Agudo, S. Bingham, D. Palli, P. Ferrari, H. Boeing, G. del Giudice, M. Plebani, et al.
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).
J Natl Cancer Inst, March 1, 2006; 98(5): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. R. DeMeester
Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment
Ann. Surg. Oncol., January 1, 2006; 13(1): 12 - 30.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. Hampel, N. S. Abraham, and H. B. El-Serag
Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications
Ann Intern Med, August 2, 2005; 143(3): 199 - 211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Correa and B. G. Schneider
Etiology of Gastric Cancer: What Is New?
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1865 - 1868.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Pohl and H. G. Welch
RESPONSE: Re: The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
J Natl Cancer Inst, July 6, 2005; 97(13): 1014 - 1014.
[Full Text] [PDF]


Home page
AAP Grand RoundsHome page
D. Kawatu and N. LeLeiko
Birth Weight, Gastroesophageal Reflux, and Adult Onset Esophageal Adenocarcinoma: A Relationship?
AAP Grand Rounds, June 1, 2005; 13(6): 69 - 70.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Kudo, O Gutierrez, H M T El-Zimaity, H Cardona, Z Z Nurgalieva, J Wu, and D Y Graham
CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer
J. Clin. Pathol., March 1, 2005; 58(3): 259 - 262.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Pohl and H. G. Welch
The Role of Overdiagnosis and Reclassification in the Marked Increase of Esophageal Adenocarcinoma Incidence
J Natl Cancer Inst, January 19, 2005; 97(2): 142 - 146.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H B El-Serag, J A Satia, and L Rabeneck
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers
Gut, January 1, 2005; 54(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Maish and S. R. DeMeester
Endoscopic Mucosal Resection as a Staging Technique to Determine the Depth of Invasion of Esophageal Adenocarcinoma
Ann. Thorac. Surg., November 1, 2004; 78(5): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. R. DeMeester
Lymph node involvement in esophageal adenocarcinoma: if you see one, have you seen them all?
J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 947 - 949.
[Full Text] [PDF]


Home page
GutHome page
I Mohammed, L F Cherkas, S A Riley, T D Spector, and N J Trudgill
Genetic influences in gastro-oesophageal reflux disease: a twin study
Gut, August 1, 2003; 52(8): 1085 - 1089.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. T. Mayne and S. A. Navarro
Diet, Obesity and Reflux in the Etiology of Adenocarcinomas of the Esophagus and Gastric Cardia in Humans
J. Nutr., November 1, 2002; 132(11): 3467S - 3470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology